Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
As part of a review of its R&D network, Eli Lilly and Company will close its neuroscience research center in Surrey, England, by the end of 2020. According to Lilly, consolidation over the years has left the site with fewer than 45 neuroscientists and 35 chemists. Remaining neuroscience activities will be shifted to the firm’s site in Cambridge, Massachusetts, while a small number of staffers will move to its Indianapolis research hub. The closure is expected to cost 80 of the 270 jobs in Surrey.
This article has been sent to the following recipient: